Muscle Loss During First‐Line Chemotherapy Impairs Survival in Advanced Pancreatic Cancer Despite Adapted Physical Activity by Pauline Parent, Frédéric Pigneur, Marc Hilmi, Aurélien Carnot, Marie‐Line Garcia Larnicol, Dewi Vernerey, Alain Luciani, Pascal Hammel, Julie Henriques, Cindy Neuzillet, Anthony Turpin

Get full text

Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trial by Emmanuel Seront, Ahmad Awada, Nieves Martinez Chanza, Philippe Barthélémy, Lieveke Ameye, Françoise Rothé, Aurélien Carnot, Nuria Kotecki, Sandrine Rorive, Thibault Tricard, Jérémy Blanc, Vinciane Casert, Brieuc Sautois, Jan Van den Brande, Vincent Vanhaudenarde, Lionel Staudacher, Veronique Debien, Jean-Christophe Fantoni, Thierry Roumeguère

Get full text

Circulating tumor DNA strongly predicts efficacy of chemotherapy plus immune checkpoint inhibitors in patients with advanced gastro-esophageal adenocarcinoma by David Tougeron, Christophe Louvet, Jérôme Desramé, Ludovic Evesque, Antoine Angelergues, Aurélien Carnot, Gilles Breysacher, Aziz Zaanan, Nicolas Etchepare, May Mabro, Laure Kaluzinski, Caroline Petorin, Benoist Chibaudel, Thomas Aparicio, Anaïs Bodere, Yves Rinaldi, Karine Le Malicot, Jean-François Emile, Côme Lepage, Aurélia Baures, Hanane Djamai, Valérie Taly, Pierre Laurent-Puig

Get full text